Navigation Links
Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
Date:4/29/2013

CHESTERBROOK, Pa. and LAKE FOREST, Ill., April 29, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that it has completed the acquisition of  Actient Holdings LLC ("Actient"), a private urology specialty therapeutics company, for $585 million in upfront cash plus certain contingent consideration and warrants to purchase Auxilium common stock.  Auxilium expects to receive a tax benefit, with a net present value of approximately $60 million, as a result of the acquisition of Actient.  The transaction is expected to be immediately accretive on a non-GAAP basis to Auxilium's 2013 adjusted net income. 

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

Actient is a private company primarily focused on urology.  Actient's urology portfolio includes TESTOPEL®, the only long-acting implantable testosterone replacement therapy ("TRT"), Edex®, the leading branded non-oral drug for erectile dysfunction, Striant®, a buccal system for testosterone delivery, and Osbon ErecAid®, a device for aiding erectile dysfunction.  Actient also has a non-promoted respiratory franchise, including Theo-24® and Semprex®-D, along with three other non-promoted products.  The company has approximately 165 employees, including 100 sales representatives in two focused field forces. 

"The acquisition of Actient is a major step forward in our strategy to expand our specialty therapeutic offerings: we believe that it expands our TRT portfolio, strengthens our commitment to urologists, enhances our growth trajectory, and will create significant value for
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013
2. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
3. Auxilium Pharmaceuticals, Inc. Announces Issuance of $350.0 Million of 1.50% Convertible Senior Notes Due 2018
4. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
5. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
6. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
7. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
8. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
9. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
10. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
11. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 Cyberonics, Inc. (NASDAQ: CYBX ... and management of epilepsy, today announced it will participate in ... Wednesday, January 14, 2015, in San Francisco ... Chief Executive Officer, will speak at 11:00 AM Pacific Time.  ... by clicking on the Investor Relations link on the Cyberonics ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today issued the following open letter to shareholders ... Dr. Med. Sc. Dear RXi Shareholders, ... number of inaccurate statements posted on certain social ...
(Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals ... 2a study of lonafarnib in patients with chronic ... conducted at the National Institutes of Health (NIH) ... .  The double-blinded, randomized, placebo-controlled, dose ascending study ... daily and 200 mg twice daily for 28 ...
Breaking Medicine Technology:RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... The U.S. Food and Drug Administration today issued new ... needle-free clinical devices to administer influenza vaccinations. Based on ... ) immediately discontinued use of such clinical devices at ... The Kroger family of pharmacies and The Little ...
... HAYWARD, Calif., Oct. 21, 2011 Intarcia ... a letter of intent with Quintiles , the world,s ... 3 program for Intarcia,s ITCA 650 (DUROS® subcutaneous continuous delivery ... GLP-1 therapy to better address the unmet needs of the ...
Cached Medicine Technology:Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 2Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 3Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 4
(Date:12/25/2014)... “Every three months the trends for evening dresses ... will be one of the hottest styles in the next ... the company releases 26 A-line sweetheart evening dresses, and announces ... , “We are trying our best to help a lady ... Along with affordable prices, we provide discounted delivery costs to ...
(Date:12/25/2014)... Recently, BellasDress has launched its Christmas ... BellasDress has chosen their best-selling lace wedding dresses, vintage ... holiday season. , Now, BellasDress.com features popular women’s ... at discount prices. The business hopes everyone can have ... , “All our elegant products are made with ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide ... Now, all of the models at LunaDress.co.uk come with big discounts, ... the wedding veil can turn out to be a most exciting ... veil can always bring surprise to a wedding. On the updated ... choose veils for a big day . , Going out ...
(Date:12/25/2014)... early stage breast cancer patients who undergo chemotherapy and/or ... eventually develop leukemia as a result of their treatment, ... a review of more than 20,000 breast cancer cases ... the risk for developing treatment-related leukemia, though low, is ... frequency of bone marrow cancers such as leukemia is ...
(Date:12/25/2014)... SmileStix ” was featured on NewsWatch as part of its ... on the iOS, Android, and Windows markets. Andrew Tropeano, a ... review and shared with viewers how this is an application ... goes, “A picture says a thousand words.” It’s true. There ... image, because each picture holds a unique and special meaning. ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... TUESDAY, June 14 (HealthDay News) -- For pregnant women, reducing ... on their left side, New Zealand researchers suggest. In ... left side had twice the risk of having a stillborn ... [from right-sided sleeping] is small for the individual," stressed lead ...
... June 15 (HealthDay News) -- Weight loss surgery patients who ... bypass have an increased risk of complications and death, a ... nearly 52,000 gastric bypass patients, researchers found that those released ... more likely to have serious complications (1.9 percent versus 0.16 ...
... , WEDNESDAY, June 15 (HealthDay News) -- Severely obese ... or become less frequent after having weight-reducing gastric bypass ... three years following surgery, 70 percent of the patients ... their migraines reduced from five to two a month, ...
... Africa Osteoporosis Meeting, to be held in Dubai, from ... , http://www.iofbonehealth.org/dubai-2011/programme.html To encourage participation by ... each for the top five abstracts by investigators up ... June 17, 2011; all accepted abstracts will be published ...
... 23andMe, a leading personal genetics company, announced that it has ... information. In the three and a half years since ... has grown to include the DNA data of more than ... for insights into their health and ancestry, more than three-fourths ...
... 2011, the New York Academy of Sciences will ... molecular biologists and patient advocates to discuss current ... and management of the cognitive symptoms of MS. ... Dysfunction in Multiple Sclerosis: New Approaches to Diagnosis ...
Cached Medicine News:Health News:Could Sleeping on Left Side Help Prevent Stillbirth? 2Health News:Could Sleeping on Left Side Help Prevent Stillbirth? 3Health News:Rushed Discharge After Weight-Loss Surgery May Raise Risks 2Health News:For Many, Weight-Loss Surgery Also Eases Migraines 2Health News:For Many, Weight-Loss Surgery Also Eases Migraines 3Health News:Program announced for 1st Middle-East & Africa Osteoporosis Meeting 2Health News:23andMe database surpasses 100,000 users 2Health News:The New York Academy of Sciences to host a symposium on cognitive dysfunction in multiple sclerosis 2
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
... Series 1000 Power Instrument System is a ... and convenience with modular and unitized handpieces., ... for use with 1025 Power Console. Accepts ... Also available without hand throttle (#1000E) for ...
... Micro Drill, without hand throttle, ... torque. Built-in medium bur guard ... (#1100-006) bur guards are also ... foot throttle (#6401-000), can also ...
Medicine Products: